FDA Approved: CARBATROL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for CARBATROL (carbamazepine) filed by Takeda Pharmaceuticals America, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Epilepsy
• Trigeminal Neuralgia

Drugs mentioned

• CARBATROL (Carbamazepine)

Snippet

SUPPL AP for CARBATROL (CARBAMAZEPINE)